Tessier, Peter M.

Glycan Determinants of Heparin-Tau Interaction

Zhao, J., Huvent, I., Lippens, G., Eliezer, D., Zhang, A., Li, Q., Tessier, P., Linhardt, R. J., Zhang, F., & Wang, C. (2017) · Biophysical Journal

Alzheimer's disease research and treatmentsGlycosylation and Glycoproteins Research

Cited by 87

Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases

Limbocker, R., Cremades, N., Cascella, R., Tessier, P. M., Vendruscolo, M., & Chiti, F. (2023) · Accounts of Chemical Research

Alzheimer's disease research and treatmentsPrion Diseases and Protein Misfolding

Cited by 48

A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training

Arsiwala, A., Bhatt, R., van Niekerk, L., Quintero-Cadena, P., Ao, X., Rosenbaum, A., Bhatt, A., Smith, A., Yang, Y., Anderson, K., et al. (2025) · mAbs

Monoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approaches

Cited by 16

A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training

Arsiwala, A., Bhatt, R., van Niekerk, L., Quintero-Cadena, P., Ao, X., Rosenbaum, A., Bhatt, A., Smith, A., Yang, Y., Anderson, K., et al. (2025) · mAbs

Monoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approaches

Cited by 16